Beauty Health (NASDAQ:SKIN – Get Free Report) and IceCure Medical (NASDAQ:ICCM – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings and risk.
Profitability
This table compares Beauty Health and IceCure Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Beauty Health | -8.11% | -44.83% | -3.54% |
| IceCure Medical | -376.85% | -124.44% | -87.70% |
Earnings and Valuation
This table compares Beauty Health and IceCure Medical”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Beauty Health | $334.29 million | 0.39 | -$100.12 million | ($0.43) | -2.44 |
| IceCure Medical | $3.29 million | 17.88 | -$14.65 million | ($0.30) | -3.53 |
IceCure Medical has lower revenue, but higher earnings than Beauty Health. IceCure Medical is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
93.3% of Beauty Health shares are held by institutional investors. Comparatively, 0.6% of IceCure Medical shares are held by institutional investors. 41.0% of Beauty Health shares are held by insiders. Comparatively, 2.4% of IceCure Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Volatility and Risk
Beauty Health has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500. Comparatively, IceCure Medical has a beta of 0.41, suggesting that its stock price is 59% less volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for Beauty Health and IceCure Medical, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Beauty Health | 1 | 3 | 1 | 0 | 2.00 |
| IceCure Medical | 0 | 0 | 1 | 1 | 3.50 |
Beauty Health presently has a consensus price target of $2.45, suggesting a potential upside of 133.33%. IceCure Medical has a consensus price target of $2.50, suggesting a potential upside of 135.85%. Given IceCure Medical’s stronger consensus rating and higher probable upside, analysts plainly believe IceCure Medical is more favorable than Beauty Health.
Summary
Beauty Health beats IceCure Medical on 8 of the 14 factors compared between the two stocks.
About Beauty Health
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
About IceCure Medical
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.
